Spots Global Cancer Trial Database for Gemcitabine With Ascorbate Including Adolescents
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Gemcitabine With Ascorbate Including Adolescents
Official Title: A Pilot Study of Gemcitabine Plus High-Dose Ascorbate in Locally Advanced Unresectable or Metastatic Soft Tissue and Bone Sarcomas Including Adolescents
Study ID: NCT04877587
Study Description
Brief Summary: The purpose of this research study is to see if a high dose of ascorbate (Vitamin C), in combination with the chemotherapy drug gemcitabine, is safe and effective in adolescents with locally advanced unresectable or metastatic soft tissue and bone sarcomas
Detailed Description: The primary objective of the expansion cohort of this pilot study is to evaluate preliminary evidence of anti-tumor activity of intravenous ascorbate in combination with gemcitabine as assessed by overall response rate to inform a subsequent Phase II trial.
Keywords
Eligibility
Minimum Age: 13 Years
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Locations
University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States
Contact Details
Name: David Dickens, MD, FAAP
Affiliation: University of Iowa Hospitals & Clinics
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
